Prevalence of Seropositivity for T. cruzi in Blood Donors of the H.C.FF.AA, period 2008-2012. Uruguay.
DOI:
https://doi.org/10.35954/SM2013.32.1.5Keywords:
Blood donors; Chagas disease, Trypanosomiasis; Uruguay/Epidemiology; Uruguay/Public Health.Abstract
Chagas disease, also known as American trypanosomiasis, is a disease considered an important public health problem, affecting mainly the population in rural and suburban areas of Latin America.
The prevalence of Chagas disease in blood banks in Uruguay, according to data reported by PAHO in 2005, was 0.47%.
The aim of this study was to determine the prevalence of seropositivity for Trypanosoma cruzi in blood donors of the Central Hospital of the Armed Forces (H.C.FF.AA) in the period 2008-2012.
An observational, descriptive, retrospective study was carried out, using as data sources the information available at the Central Laboratory, Serology Section of the H.C.FF.AA.
The prevalence of donors seropositive for Trypanosoma cruzi found in the period analyzed was 0.20%.
The migration of people infected with T. cruzi from endemic areas to non-endemic countries generates a new public health problem for these countries due to the risk of blood transmission. Screening in blood banks is a fundamental tool in the control of this disease through the identification of cases.
Downloads
Metrics
References
(1) Salvatella R. Aspectos Epidemiológicos de la Enfermedad de Chagas. ( 8 páginas en pantalla). Disponible en: http://enfermedadchagas.com.ar/epidem.pdf [Consulta 05/03/2012].
(2) Jannin J, Salvatella R. Editores. Estimación cuantitativa de la enfermedad de Chagas en las Américas. Montevideo: OPS, 2006.
(3) Conti Díaz I. A propósito del Centenario del descubrimiento de la Enfermedad de Chagas. Análisis cronológico de los principales hitos en la evolución de su conocimiento y control con particular énfasis en las contribuciones científicas uruguayas. Rev Méd Urug 2010; 26(2):108-116.
(4) Salvatella R. Una visión de la enfermedad de Chagas desde su propia historia. En: La enfermedad de Chagas a la puerta de los 100 años del conocimiento de una endemia americana ancestral. Buenos Aires: Organización Panamericana de la Salud/Fundación Mundo Sano; 2007. p. 19-22.
(5) Departamento de Parasitología y Micología. Enfermedad de Chagas. Sección Chagas 2007. Disponible en: http://www.higiene.edu.uy/parasito/teo09/Ciclip/enfchag.pdf [Consulta 05/03/2013]
(6) Bwititi PT, Browne J. Seroprevalencia de Trypanosoma cruzi en donantes de sangre en los servicios nacionales de transfusión de sangre: Guyana. West Indian med J 2012; 61(6): 559-563. Disponible en: http://caribbean.scielo.org/scielo.php?script=sci_arttext&pid=S0043-31442012000600002&lng=es [Consulta 05/03/2013]
(7) Blejer J, Saguier M, Dinapoli R, Salamone H. Prevalencia de Anticuerpos Anti-tripanosoma cruzi en donantes de sangre. Medicina (Bs As)1999; 59(2):129-132.
Published
How to Cite
Issue
Section
License
Until 2024 we use the Creative Commons Attribution/NonCommercial Attribution 4.0 International License https://creativecommons.org/licenses/by-nc/4.0/deed.es. Which states that: you are free to share, copy and redistribute the material in any medium or format, as well as to adapt, remix, transform and build upon the material. Under the following terms:
Attribution: you must give proper credit , provide a link to the license, and indicate if changes have been made . You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
NonCommercial: you may not use the material for commercial purposes.
As of 2025 authors retain their copyright and assign to the journal the right of first publication of their work, which shall simultaneously be subject to the license https://creativecommons.org/licenses/by-nc-sa/4.0/deed.es that permits sharing, copying and redistribution of the material in any medium or format provided that initial publication in this journal is indicated. Adapt, remix, transform and build upon the material. If you remix, transform, or build from the material, you must distribute your contribution under the same license as the original and may not make use of the material for commercial purposes.
Under the following terms:
1. Attribution: you must give proper credit, provide a link to the license, and indicate whether changes have been made. You may do so in any reasonable manner, but not in such a way as to suggest that you or your use is endorsed by the licensor.
2. NonCommercial: you may not use the material for commercial purposes.
3. ShareAlike: if you remix, transform or build upon the material, you must distribute your contribution under the same license as the original.
PlumX Metrics
/
